查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
术中神经监测市场规模、份额和成长分析（按产品/服务、来源类型、应用和地区划分）—产业预测（2026-2033 年）
市场调查报告书
商品编码
1898463

术中神经监测市场规模、份额和成长分析（按产品/服务、来源类型、应用和地区划分）—产业预测（2026-2033 年）

Intraoperative Neuromonitoring Market Size, Share, and Growth Analysis, By Product and Services (Systems, Disposables), By Source Type (Insourced Monitoring, Insourced Monitoring), By Application, By Region -Industry Forecast 2026-2033
出版日期: | 出版商: SkyQuest | 英文 165 Pages | 商品交期: 3-5个工作天内

价格
简介目录

预计到 2024 年，术中神经监测 (IONM) 市场规模将达到 34.3 亿美元，到 2025 年将达到 35.9 亿美元，到 2033 年将达到 52.3 亿美元，在预测期（2026-2033 年）内，复合年增长率为 4.8%。

术中神经监测市场正经历显着增长，这主要得益于微创手术需求的不断增长以及手术病患监测的进步，从而提高了手术安全性并减少了併发症。这一趋势为改善患者照护和优化术后管理提供了重要机会。在手术过程中，尤其是在脊椎手术中，监测肌肉功能健康状况已成为製造商关注的重点，推动了对术中神经监测（IONM）等监测技术的兴趣日益浓厚。此外，专有软体和术中关节镜设备的进步正在增强即时决策能力，从而实现更安全、更有效率的手术。该市场的竞争格局涵盖了领先的医疗设备製造商、专业服务供应商以及远端监测领域的创新者，他们都在透过伙伴关係和区域扩张来推动技术创新。这使得术中神经监测在全球范围内更加普及和高效。

术中神经监测市场驱动因素

复杂外科手术，尤其是肌肉骨骼手术的增加，显着地推动了术中神经监测（IONM）市场的发展。随着人们越来越重视改善术后復健效果和病人安全，这些复杂手术对IONM服务的依赖也日益增强。此外，开发中国家医疗保健系统的进步，加上人口老化和文明病的流行，也促使外科手术数量激增。这些因素共同推动了对IONM的需求，使其成为确保手术成功的关键工具。

限制术中神经监测市场的因素

术中神经监测市场成长的主要障碍之一是技术实施和有效操作所需专业技能带来的沉重经济负担。购买一套先进的术中神经监测系统需要大量的初始投资，并且还需要持续的维护和营运成本。此外，提供术中神经监测服务通常需要训练有素的专业人员，他们凭藉高超的技能和丰富的经验，获得极具竞争力的薪资。这些因素共同导致了将术中神经监测整合到外科手术流程中的高成本，阻碍了其广泛应用。

术中神经监测市场趋势

术中神经监测市场近年来呈现显着的发展趋势，这主要得益于人工智慧 (AI) 和机器学习 (ML) 技术的融合应用。这些技术的进步显着提升了监测系统的准确性和预测能力，从而能够快速分析大量资料。透过检测神经讯号中预示潜在併发症的细微模式，AI 驱动的术中神经监测系统有助于及时做出决策，并最终改善患者预后。此外，监测流程的自动化最大限度地减少了人为干预，并确保了系统在应对营运中断方面的韧性。随着医疗保健领域数位化解决方案的日益普及，AI 和 ML 在术中神经监测中的作用将不断扩大，使其在外科手术环境中发挥更重要的作用。

目录

介绍

  • 调查目标
  • 定义
  • 市场覆盖范围

调查方法

  • 资讯收集
  • 二手和一手资讯来源
  • 市场规模预测
  • 市场假设与限制

执行摘要

    前景
  • 供需趋势分析
  • 细分市场机会分析

市场动态与展望

  • 市场动态
    • 司机
    • 机会
    • 抑制因素
    • 任务
  • 波特分析

关键市场考察

  • 技术分析
  • 定价分析
  • 价值链分析
  • 市场生态系统
  • 贸易分析
  • 供应链分析
  • 用例分析
  • 专利分析
  • 客户和购买标准分析
  • 监管环境
  • 创新矩阵
  • 主要投资分析
  • 关键成功因素
  • 竞争程度

术中神经监测市场（依产品/服务划分）

  • 系统
  • 配件
  • 服务

术中神经监测市场依来源类型划分

  • 内部监控
  • 外包监控

按应用分類的术中神经监测市场

  • 脊椎手术
  • 神经外科
  • 整形外科手术
  • 耳鼻喉科手术
  • 血管外科
  • 其他外科手术

按模式分類的术中神经监测市场

  • 运动诱发电位（MEP）
  • 体感诱发电位（SSEPs）
  • 脑电图（EEG）
  • 肌电图（EMG）
  • 脑干听觉诱发电位（BAEP）
  • 视觉诱发电位（VEP）

按最终用户分類的术中神经监测市场

  • 医院
  • 门诊手术中心（ASC）

按地区分類的术中神经监测市场规模

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 义大利
    • 其他欧洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲
  • 中东和非洲
    • GCC
    • 南非
    • 其他中东和非洲地区

竞争格局

  • 前五大公司对比
  • 主要企业的市场定位（2025 年）
  • 主要市场参与者所采取的策略
  • 近期市集活动
  • 主要企业市占率（2025 年）

主要企业简介

  • 内特斯医疗公司（美国）
  • 精准监测（美国）
  • 神经监测技术（美国）
  • 美敦力（爱尔兰）
  • NuVasive公司（美国）
  • SpecialtyCare（美国）
  • 卡德威尔工业公司（美国）
  • Alpha Omega Engineering, Inc.（美国）
  • BIoTronic NeuroNetwork（美国）
  • IntraOp Medical Corporation（美国）
  • NeuroWave Systems, Inc.（美国）
  • Integra LifeSciences Corporation（美国）
  • Zynex公司（美国）
  • 美敦力（爱尔兰）
  • 史赛克公司（美国）
  • 神经监测服务公司（美国）
  • 神经诊断服务（美国）
  • Aesculap公司（美国）
  • Elekta AB（瑞典）
  • OrLive（美国）
  • Stimwave Technologies（美国）
简介目录
Product Code: SQMIG35D2016

Intraoperative Neuromonitoring Market size was valued at USD 3.43 Billion in 2024 and is poised to grow from USD 3.59 Billion in 2025 to USD 5.23 Billion by 2033, growing at a CAGR of 4.8% during the forecast period (2026-2033).

The intraoperative neuromonitoring market is experiencing substantial growth driven by the rising demand for minimally invasive procedures and improved surgical patient monitoring that enhances safety and reduces complications. This trend presents significant opportunities to elevate patient care and optimize postoperative management. Monitoring muscle health during surgical interventions, particularly in spinal procedures, has become a critical factor for manufacturers, fostering increased interest in monitoring technologies like IONM. Additionally, proprietary software and intraoperative arthroscopy devices are enhancing real-time decision-making, resulting in safer and more efficient surgeries. The competitive landscape features medical device giants, specialty service providers, and innovators in remote monitoring, all fostering partnerships and regional expansions to drive continuous technological advancements, ultimately making intraoperative neuromonitoring more accessible and efficient on a global scale.

Top-down and bottom-up approaches were used to estimate and validate the size of the Intraoperative Neuromonitoring market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Intraoperative Neuromonitoring Market Segments Analysis

Global Intraoperative Neuromonitoring Market is segmented by Products and Services, Source Type, Application, Modality, End User, and region. Based on Products and Services, the market is segmented into Systems, Accessories, and Services. Based on Source Type, the market is segmented into Insourced Monitoring, and Outsourced Monitoring. Based on Application, the market is segmented into Spinal Surgery, Neurosurgery, Orthopedic Surgery, ENT Surgery, Vascular Surgery, and Other surgeries. Based on Modality, the market is segmented into Motor evoked potentials (MEPs), Somatosensory evoked potentials (SSEPs), Electroencephalography (EEG),Electromyography(EMG), Brainstem auditory evoked potentials (BAEPs), and Visual evoked potentials (VEPs). Based on End User, the market is segmented into Hospitals, and Ambulatory Surgical Centers (ASCs). Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Intraoperative Neuromonitoring Market

The rise in complex surgical procedures, particularly in the field of musculoskeletal surgeries, is significantly propelling the Intraoperative Neuromonitoring (IONM) market. There is a growing emphasis on enhancing recovery outcomes and patient safety, which has spurred an increased reliance on IONM services during these intricate operations. Additionally, advancements in healthcare systems within developing countries are contributing to a surge in surgical interventions, driven by an aging population and the prevalence of lifestyle-related health issues. This convergence of factors is creating a heightened demand for IONM as a vital tool in ensuring successful surgical results.

Restraints in the Intraoperative Neuromonitoring Market

One of the primary obstacles hindering the growth of the intraoperative neuromonitoring (IONM) market is the significant financial burden linked to both the technology and the specialized knowledge necessary for effective implementation. The initial investment needed to procure advanced IONM systems can be substantial, alongside continuous expenses for maintenance and operation. Additionally, the provision of IONM services typically requires highly trained professionals, whose expertise commands competitive salaries due to the skill level and proficiency involved. These factors collectively contribute to the high costs associated with integrating IONM into surgical practices, posing a barrier to widespread adoption.

Market Trends of the Intraoperative Neuromonitoring Market

The Intraoperative Neuromonitoring (IONM) market is witnessing a significant trend driven by the integration of Artificial Intelligence (AI) and Machine Learning (ML) technologies. These advancements are enhancing the accuracy and predictive capabilities of monitoring systems, allowing for rapid analysis of extensive datasets. By detecting subtle patterns in neural signals indicative of potential complications, AI-powered IONM systems facilitate timely decision-making and improve patient outcomes. Moreover, the automation of monitoring processes minimizes the need for extensive human intervention, ensuring resilience against operational disruptions. As the healthcare sector increasingly adopts digital solutions, the role of AI and ML in IONM will continue to expand, reinforcing their importance in surgical settings.

Table of Contents

Introduction

  • Objectives of the Study
  • Definitions
  • Market Scope

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Market Overview Outlook
  • Supply Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • Trade Analysis
  • Supply chain Analysis
  • Case study Analysis
  • Patent Analysis
  • Customer & Buying Criteria Analysis
  • Regulatory Landscape
  • Innovation Matrix
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Intraoperative Neuromonitoring Market by Products and Services

  • Market Overview
  • Systems
  • Accessories
  • Services

Intraoperative Neuromonitoring Market by Source Type

  • Market Overview
  • Insourced Monitoring
  • Outsourced Monitoring

Intraoperative Neuromonitoring Market by Application

  • Market Overview
  • Spinal Surgery
  • Neurosurgery
  • Orthopedic Surgery
  • ENT Surgery
  • Vascular Surgery
  • Other surgeries

Intraoperative Neuromonitoring Market by Modality

  • Market Overview
  • Motor evoked potentials (MEPs)
  • Somatosensory evoked potentials (SSEPs)
  • Electroencephalography (EEG)
  • Electromyography (EMG)
  • Brainstem auditory evoked potentials (BAEPs)
  • Visual evoked potentials (VEPs)

Intraoperative Neuromonitoring Market by End User

  • Market Overview
  • Hospitals
  • Ambulatory Surgical Centers (ASCs)

Intraoperative Neuromonitoring Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2025

Key Company Profiles

  • Natus Medical Incorporated (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Accurate Monitoring (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Neuromonitoring Technologies (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtronic (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • NuVasive, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • SpecialtyCare (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cadwell Industries, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Alpha Omega Engineering, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biotronic NeuroNetwork (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • IntraOp Medical Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • NeuroWave Systems, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Integra LifeSciences Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Zynex, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtronic (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Stryker Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nerve Monitoring Services, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Neurodiagnostic Services (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Aesculap, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Elekta AB (Sweden)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • OrLive (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Stimwave Technologies (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments